Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects

Amides containing methyl esters of γ-aminobutyric acid (GABA), L-proline and L-tyrosine, and esters containing 3-(pyridin-3-yl)propan-1-ol were synthesized by conjugation with 3,5-di-<i>tert</i>-butyl-4-hydroxybenzoic, an NSAID (tolfenamic acid), or 3-phenylacrylic (cinnamic, (<i>E...

Full description

Bibliographic Details
Main Authors: Panagiotis Theodosis-Nobelos, Gabriel Marc, Eleni A. Rekka
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/5/1016
_version_ 1797264178167152640
author Panagiotis Theodosis-Nobelos
Gabriel Marc
Eleni A. Rekka
author_facet Panagiotis Theodosis-Nobelos
Gabriel Marc
Eleni A. Rekka
author_sort Panagiotis Theodosis-Nobelos
collection DOAJ
description Amides containing methyl esters of γ-aminobutyric acid (GABA), L-proline and L-tyrosine, and esters containing 3-(pyridin-3-yl)propan-1-ol were synthesized by conjugation with 3,5-di-<i>tert</i>-butyl-4-hydroxybenzoic, an NSAID (tolfenamic acid), or 3-phenylacrylic (cinnamic, (<i>E</i>)-3-(3,4-dimethoxyphenyl)acrylic and caffeic) acids. The rationale for the conjugation of such moieties was based on the design of structures with two or more molecular characteristics. The novel compounds were tested for their antioxidant, anti-inflammatory and hypolipidemic properties. Several compounds were potent antioxidants, comparable to the well-known antioxidant, Trolox. In addition, the radical scavenging activity of compound <b>6</b> reached levels that were slightly better than that of Trolox. All the tested compounds demonstrated remarkable activity in the reduction in carrageenan-induced rat paw edema, up to 59% (compound <b>2</b>, a dual antioxidant and anti-inflammatory molecule, with almost 2.5-times higher activity in this experiment than the parent NSAID). Additionally, the compounds caused a significant decrease in the plasma lipidemic indices in Triton-induced hyperlipidemic rats. Compound <b>2</b> decreased total cholesterol by 75.1% and compound <b>3</b> decreased triglycerides by 79.3% at 150 μmol/kg (i.p.). The hypocholesterolemic effect of the compounds was comparable to that of simvastatin, a well-known hypocholesterolemic drug. Additionally, all compounds lowered blood triglycerides. The synthesized compounds with multiple activities, as designed, may be useful as potential candidates for conditions involving inflammation, lipidemic deregulation and oxygen toxicity.
first_indexed 2024-04-25T00:24:46Z
format Article
id doaj.art-b91f5d5c3e0b43bb8192bd9c5a0a9da8
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-25T00:24:46Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b91f5d5c3e0b43bb8192bd9c5a0a9da82024-03-12T16:50:46ZengMDPI AGMolecules1420-30492024-02-01295101610.3390/molecules29051016Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering EffectsPanagiotis Theodosis-Nobelos0Gabriel Marc1Eleni A. Rekka2Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, CyprusDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy, 41 Victor Babeș Street, RO-400010 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotelian University of Thessaloniki, 54124 Thessaloniki, GreeceAmides containing methyl esters of γ-aminobutyric acid (GABA), L-proline and L-tyrosine, and esters containing 3-(pyridin-3-yl)propan-1-ol were synthesized by conjugation with 3,5-di-<i>tert</i>-butyl-4-hydroxybenzoic, an NSAID (tolfenamic acid), or 3-phenylacrylic (cinnamic, (<i>E</i>)-3-(3,4-dimethoxyphenyl)acrylic and caffeic) acids. The rationale for the conjugation of such moieties was based on the design of structures with two or more molecular characteristics. The novel compounds were tested for their antioxidant, anti-inflammatory and hypolipidemic properties. Several compounds were potent antioxidants, comparable to the well-known antioxidant, Trolox. In addition, the radical scavenging activity of compound <b>6</b> reached levels that were slightly better than that of Trolox. All the tested compounds demonstrated remarkable activity in the reduction in carrageenan-induced rat paw edema, up to 59% (compound <b>2</b>, a dual antioxidant and anti-inflammatory molecule, with almost 2.5-times higher activity in this experiment than the parent NSAID). Additionally, the compounds caused a significant decrease in the plasma lipidemic indices in Triton-induced hyperlipidemic rats. Compound <b>2</b> decreased total cholesterol by 75.1% and compound <b>3</b> decreased triglycerides by 79.3% at 150 μmol/kg (i.p.). The hypocholesterolemic effect of the compounds was comparable to that of simvastatin, a well-known hypocholesterolemic drug. Additionally, all compounds lowered blood triglycerides. The synthesized compounds with multiple activities, as designed, may be useful as potential candidates for conditions involving inflammation, lipidemic deregulation and oxygen toxicity.https://www.mdpi.com/1420-3049/29/5/1016antioxidantsNSAIDanti-inflammatorydyslipidemiaantioxidant activitypluripotent derivatives
spellingShingle Panagiotis Theodosis-Nobelos
Gabriel Marc
Eleni A. Rekka
Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
Molecules
antioxidants
NSAID
anti-inflammatory
dyslipidemia
antioxidant activity
pluripotent derivatives
title Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
title_full Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
title_fullStr Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
title_full_unstemmed Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
title_short Design, Synthesis and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory and Plasma Lipid Lowering Effects
title_sort design synthesis and evaluation of antioxidant and nsaid derivatives with antioxidant anti inflammatory and plasma lipid lowering effects
topic antioxidants
NSAID
anti-inflammatory
dyslipidemia
antioxidant activity
pluripotent derivatives
url https://www.mdpi.com/1420-3049/29/5/1016
work_keys_str_mv AT panagiotistheodosisnobelos designsynthesisandevaluationofantioxidantandnsaidderivativeswithantioxidantantiinflammatoryandplasmalipidloweringeffects
AT gabrielmarc designsynthesisandevaluationofantioxidantandnsaidderivativeswithantioxidantantiinflammatoryandplasmalipidloweringeffects
AT eleniarekka designsynthesisandevaluationofantioxidantandnsaidderivativeswithantioxidantantiinflammatoryandplasmalipidloweringeffects